Written answers

Tuesday, 27 July 2021

Photo of David CullinaneDavid Cullinane (Waterford, Sinn Fein)
Link to this: Individually | In context | Oireachtas source

1815. To ask the Minister for Health if he will advise on a matter raised in correspondence (details supplied) in relation to long Covid; and if he will make a statement on the matter. [35556/21]

Photo of Stephen DonnellyStephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

Covid-19 is a new disease so information on it, its features and its course are still emerging. Scientific and clinical evidence is evolving on the long-term effects of COVID-19. An increasing number of reports and studies are now being published on the topic, however, at present there is no agreement on the definition or the terminology.

Scientific and clinical evidence is evolving on the long-term effects of COVID-19. It is recognised that persistent and prolonged symptoms can occur after acute COVID-19 infection in a proportion of patients, including in some patients who did not develop symptoms severe enough to require hospitalisation. My Department, through the Health Research Board, continues to fund research into the clinical impacts of COVID-19.

Patients with persistent symptoms following Covid-19 infection may be followed up by their GP or in hospital settings as clinically appropriate. People in the community who are concerned about persistent symptoms following Covid-19 should contact their GP in the first instance. Treatment is currently focused on management of specific symptoms. In line with Sláintecare, we need to ensure that as much reablement and rehabilitation care as possible is delivered in the community, as close to people’s homes as possible. General practice plays a key part in the delivery of a national post-acute (Long) COVID-19 service.

Specific guidance on the treatment of Long Covid is presently under development both here and internationally.

The HSE is assessing need and the best way to care for those impacted by Long COVID. I can advise the Deputy that the HSE as part of its work on post-Covid care, is now looking at how it can model the possible numbers that will be affected, noting that this will take time as more evidence emerges. I understand that the HSE has been in touch with a group of people who are suffering post-Covid symptoms to inform understanding. Guidance is being developed to align needs with care provision and to develop criteria and strategies for the ongoing evaluation of patients.

The Department of Health will continue to develop an understanding of the implications of Long Covid to inform policy as appropriate.

Under the Health Act 1970 (as amended), eligibility for a medical card is based primarily on means. The Act obliges the HSE to assess whether a person is unable, without undue hardship, to arrange general practitioner services for himself or herself and his or her family, having regard to his or her overall financial position and reasonable expenditure. The issue of granting medical cards based on having a particular disease or illness was previously examined in 2014 by the HSE Expert Panel on Medical Need and Medical Card Eligibility. The Group concluded that it was not feasible, desirable, nor ethically justifiable to list medical conditions in priority order for medical card eligibility. In following the Expert Group’s advice, a person’s means remains the main qualifier for a medical card.

However, every effort is made by the HSE, within the framework of the legislation, to support applicants in applying for a medical card and, in particular, to take full account of the difficult circumstances in the case of applicants who may be in excess of the income guidelines. The HSE may exercise discretion and grant a medical card, even though an applicant exceeds the income threshold where they face difficult financial circumstances, such as extra costs arising from, the social and medical impacts of an illness.

The Disability Allowance and Illness Benefit Schemes do not fall under the remit of my Department, however information on the scheme and how to apply can be found at www.gov.ie/en/service/df6811-disability-allowance/ and www.gov.ie/en/service/ddf6e3-illness-benefit/.

Photo of Colm BurkeColm Burke (Cork North Central, Fine Gael)
Link to this: Individually | In context | Oireachtas source

1816. To ask the Minister for Health the procedures that will be put in place for persons who travel to Ireland and who have clear evidence that they have received a Covid-19 vaccine (details supplied); and if there has been any communication with the European Medicines Agency regarding the approval of this vaccine. [35557/21]

Photo of Stephen DonnellyStephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

Under current travel regulations 'Vaccinated Person' means a person vaccinated with an EMA approved vaccine, with recommended number of days after the final dose. The following table sets out timelines for the four different vaccinations being used.

2 doses of Pfizer-BioNtech Vaccine: BNT162b2 (Comirnaty®) Plus 7 days
2 doses of Moderna Vaccine: CX-024414 (Moderna®) Plus 14 days
2 doses of Oxford-AstraZeneca Vaccine: ChAdOx1-SARS-COV-2 (Vaxzevria® or Covishield) Plus 15 days
1 dose of Johnson & Johnson/Janssen Vaccine: Ad26.COV2-S [recombinant] (Janssen®) Plus 14 days

Travellers into Ireland can provide proof of vaccination with EMA approved vaccines, proof of recovery, or a valid negative PCR-RT test result under the current travel measures.

There is comprehensive information on international travel on gov.ie/travel and www.dfa/travel

Comments

No comments

Log in or join to post a public comment.